Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia

Am J Hematol. 1986 Aug;22(4):391-401. doi: 10.1002/ajh.2830220408.

Abstract

Platelet function was evaluated in 20 patients with chronic myelocytic leukemia (CML), all Ph positive. Seven showed abnormal epinephrine-induced aggregation, while four had impaired both ADP- and collagen-induced aggregation. The platelets of all patients aggregated with arachidonic acid, thus ruling out cyclooxygenase or lipoxygenase deficiency. The intracellular concentrations of ATP and ADP were significantly below normal, and the ratio of ATP/ADP was greater than normal in all 12 patients. ATP released from platelets by Lumi-aggregometer was reduced. In four patients with abnormal ristocetin-induced aggregation, vWF:Ag, RCoF, and FVIII:C were all reduced. No significant inactivation of factor VIII was induced in normal plasma by incubation with patient's plasma. The crossed immunoelectrophoretic analysis revealed that vWF:Ag in these patients was mainly composed of more anodic component as compared with that of normal plasma. The ratio of vWF:Ag/RCoF was significantly greater than normal. A marked increase of factor VIII and a rapid return of vWF:Ag and RCoF to the baseline after the 1-deamino-8-arginine vasopressin (DDAVP) infusion were observed. Transient increase in vWF:Ag after the infusion of DDAVP appeared with less anodic forms and in the same relative proportion as that in normal plasma. The present study shows that in some patients with CML storage pool disease occurs with acquired von Willebrand disease.

MeSH terms

  • Adenosine Triphosphate / blood
  • Adult
  • Blood Coagulation Tests
  • Blood Platelet Disorders / etiology*
  • Blood Platelets / metabolism
  • Deamino Arginine Vasopressin / administration & dosage
  • Humans
  • Leukemia, Myeloid / blood
  • Leukemia, Myeloid / complications*
  • Middle Aged
  • Platelet Aggregation
  • Platelet Storage Pool Deficiency / blood
  • Platelet Storage Pool Deficiency / etiology*
  • von Willebrand Diseases / blood
  • von Willebrand Diseases / etiology*

Substances

  • Adenosine Triphosphate
  • Deamino Arginine Vasopressin